Announcements

Home > Investor Relations >Announcements
Back List
Reelection of the company chairman and vice chairman date : 2025/05/29

SEQ_NO

5

Date of announcement

2025/05/29

Time of announcement

14:38:02

Spokesman:

Chen, Ying-Chi

Title of Spokesman:

Vice President of Sales Division

Subject

Reelection of the company chairman and vice chairman.

To which item it meets

paragraph 6

Date of events

2025/05/29

Statement

1.Date of the board of directors resolution or date of occurrence of

   the change:2025/05/29

2.Position (Please enter chairperson or president/general manager):

chairperson and vice chairperson

3.Name of the previous position holder:

 (A)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang Hsieh, I-Chen

 (B)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang, Hou-Kai

4.Resume of the previous position holder:

 (A)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang Hsieh, I-Chen / the company Chairman

 (B)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang, Hou-Kai / the company Vice Chairman

5.Name of the new position holder:

 (A)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang Hsieh, I-Chen

 (B)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang, Hou-Kai

6.Resume of the new position holder:

 (A)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang Hsieh, I-Chen / the company Chairman

 (B)Representative of China Chemical & Pharmaceutical Co., Ltd./

      Wang, Hou-Kai / the company Vice Chairman

7.Circumstances of change (Please enter "resignation", "dismissal",

"term expired" , "job relocation", "severance", "retirement",

"death" or "new appointment"): term expired

8.Reason for the change: Tenure expired, Re-election of directors

9.Effective date of the new appointment: 2025/05/29

10.Any other matters that need to be specified (the information

disclosure also meets the requirements of Article 7,

subparagraph 6 of the Securities and Exchange Act

Enforcement Rules, which brings forth a significant impact

    on shareholders rights or the price of the securities on public

    companies.): None